Concurrent Investment Advisors LLC Raises Stake in Kenvue Inc. $KVUE

Key Points

• Concurrent Investment Advisors LLC increased its stake in Kenvue Inc. by 30.5% during the second quarter, holding a total of 75,883 shares valued at $1.588 million.
• Kenvue reported $0.29 earnings per share for the last quarter, surpassing the estimate of $0.28, although the revenue of $3.84 billion was down 4.0% year-over-year.
• The company recently declared a quarterly dividend of $0.2075 per share, representing a yield of 5.1%, which is an increase from the prior dividend of $0.21.

Concurrent Investment Advisors LLC boosted its position in Kenvue Inc. (NYSE:KVUE - Free Report) by 30.5% in the 2nd quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The institutional investor owned 75,883 shares of the company's stock after buying an additional 17,748 shares during the quarter. Concurrent Investment Advisors LLC's holdings in Kenvue were worth $1,588,000 as of its most recent filing with the Securities and Exchange Commission (SEC).

Several other hedge funds and other institutional investors have also bought and sold shares of the company. Evergreen Wealth Solutions LLC raised its holdings in shares of Kenvue by 2.6% during the first quarter. Evergreen Wealth Solutions LLC now owns 16,769 shares of the company's stock valued at $402,000 after acquiring an additional 432 shares in the last quarter. Scott & Selber Inc. raised its holdings in shares of Kenvue by 0.4% during the first quarter. Scott & Selber Inc. now owns 106,621 shares of the company's stock valued at $2,557,000 after acquiring an additional 475 shares in the last quarter. Wealth Alliance LLC raised its holdings in shares of Kenvue by 1.6% during the first quarter. Wealth Alliance LLC now owns 31,778 shares of the company's stock valued at $762,000 after acquiring an additional 486 shares in the last quarter. Everett Harris & Co. CA raised its holdings in shares of Kenvue by 1.4% during the first quarter. Everett Harris & Co. CA now owns 36,971 shares of the company's stock valued at $887,000 after acquiring an additional 500 shares in the last quarter. Finally, Proffitt & Goodson Inc. raised its holdings in shares of Kenvue by 8.2% during the second quarter. Proffitt & Goodson Inc. now owns 6,831 shares of the company's stock valued at $143,000 after acquiring an additional 517 shares in the last quarter. Hedge funds and other institutional investors own 97.64% of the company's stock.

Kenvue Price Performance

Shares of NYSE:KVUE opened at $16.25 on Thursday. Kenvue Inc. has a 1-year low of $15.47 and a 1-year high of $25.17. The company has a debt-to-equity ratio of 0.66, a current ratio of 0.98 and a quick ratio of 0.68. The business has a fifty day moving average price of $18.82 and a 200-day moving average price of $21.18. The company has a market capitalization of $31.19 billion, a PE ratio of 21.96, a PEG ratio of 2.32 and a beta of 0.72.

Kenvue (NYSE:KVUE - Get Free Report) last issued its quarterly earnings results on Thursday, August 7th. The company reported $0.29 earnings per share for the quarter, beating the consensus estimate of $0.28 by $0.01. Kenvue had a return on equity of 20.06% and a net margin of 9.37%.The firm had revenue of $3.84 billion during the quarter, compared to the consensus estimate of $3.94 billion. During the same period last year, the company earned $0.32 earnings per share. The company's revenue was down 4.0% on a year-over-year basis. Kenvue has set its FY 2025 guidance at 1.000-1.050 EPS. As a group, equities analysts expect that Kenvue Inc. will post 1.14 EPS for the current fiscal year.

Kenvue Increases Dividend

The business also recently declared a quarterly dividend, which was paid on Wednesday, August 27th. Stockholders of record on Wednesday, August 13th were issued a dividend of $0.2075 per share. The ex-dividend date was Wednesday, August 13th. This is a boost from Kenvue's previous quarterly dividend of $0.21. This represents a $0.83 annualized dividend and a dividend yield of 5.1%. Kenvue's dividend payout ratio is 112.16%.

Wall Street Analyst Weigh In

KVUE has been the subject of a number of recent analyst reports. The Goldman Sachs Group decreased their target price on Kenvue from $22.00 to $19.00 and set a "neutral" rating for the company in a report on Thursday, October 2nd. Rothschild & Co Redburn upgraded Kenvue from a "neutral" rating to a "buy" rating and decreased their price objective for the stock from $22.50 to $22.00 in a report on Friday, September 26th. Royal Bank Of Canada lowered their price objective on Kenvue from $24.00 to $22.00 and set a "sector perform" rating for the company in a research report on Friday, August 8th. Evercore ISI lowered their price objective on Kenvue from $23.00 to $18.00 and set an "in-line" rating for the company in a research report on Tuesday, September 23rd. Finally, Citigroup lowered their price objective on Kenvue from $20.00 to $17.00 and set a "neutral" rating for the company in a research report on Thursday, October 9th. One analyst has rated the stock with a Strong Buy rating, five have issued a Buy rating, nine have given a Hold rating and one has assigned a Sell rating to the stock. According to data from MarketBeat, the company currently has an average rating of "Hold" and a consensus target price of $21.18.

Kenvue Company Profile

Kenvue Inc operates as a consumer health company worldwide. The company operates through three segments: Self Care, Skin Health and Beauty, and Essential Health. The Self Care segment offers cough, cold and allergy, pain care, digestive health, smoking cessation, eye care, and other products under the Tylenol, Motrin, Benadryl, Nicorette, Zarbee's, ORSLTM, Rhinocort, Calpol, and Zyrtec brands.

Want to see what other hedge funds are holding KVUE? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Kenvue Inc. (NYSE:KVUE - Free Report).

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.